Medtronic Posts Q1 Beat, 2027 Outlook Raise Validates Growth Inflection

기사 요약

MDT shares rise after Q1 beat and raised FY27 growth guidance. Analysts maintain Buy/Outperform ratings, citing broad-based strength.